Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ALBATROSS trial of early aldosterone blockade after acute myocardial infarction
2008-006857-42Phase 3Active
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Aug 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of spironolactone and potassium canrenoate in myocardial infarction (MI) (2 arms), sponsored by Assistance publique - Hôpitaux de Paris. Started Aug 2009; status: active.
02
Drugs
spironolactonepotassium canrenoate
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on 2008-006857-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-006857-42.